These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 8074809)
1. A soluble immunoglobulin variable domain without a disulfide bridge: construction, accumulation in the cytoplasm of E. coli, purification and physicochemical characterization. Frisch C; Kolmar H; Fritz HJ Biol Chem Hoppe Seyler; 1994 May; 375(5):353-6. PubMed ID: 8074809 [TBL] [Abstract][Full Text] [Related]
2. X-ray crystallography reveals stringent conservation of protein fold after removal of the only disulfide bridge from a stabilized immunoglobulin variable domain. Usón I; Bes MT; Sheldrick GM; Schneider TR; Hartsch T; Fritz HJ Fold Des; 1997; 2(6):357-61. PubMed ID: 9427009 [TBL] [Abstract][Full Text] [Related]
3. Contribution of the intramolecular disulfide bridge to the folding stability of REIv, the variable domain of a human immunoglobulin kappa light chain. Frisch C; Kolmar H; Schmidt A; Kleemann G; Reinhardt A; Pohl E; Usón I; Schneider TR; Fritz HJ Fold Des; 1996; 1(6):431-40. PubMed ID: 9080189 [TBL] [Abstract][Full Text] [Related]
4. Intrabody construction and expression. II. A synthetic catalytic Fv fragment. Ohage EC; Wirtz P; Barnikow J; Steipe B J Mol Biol; 1999 Sep; 291(5):1129-34. PubMed ID: 10518948 [TBL] [Abstract][Full Text] [Related]
5. Intrabody construction and expression. I. The critical role of VL domain stability. Ohage E; Steipe B J Mol Biol; 1999 Sep; 291(5):1119-28. PubMed ID: 10518947 [TBL] [Abstract][Full Text] [Related]
6. Removal of the conserved disulfide bridges from the scFv fragment of an antibody: effects on folding kinetics and aggregation. Ramm K; Gehrig P; Plückthun A J Mol Biol; 1999 Jul; 290(2):535-46. PubMed ID: 10390351 [TBL] [Abstract][Full Text] [Related]
7. A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding. Proba K; Honegger A; Plückthun A J Mol Biol; 1997 Jan; 265(2):161-72. PubMed ID: 9020980 [TBL] [Abstract][Full Text] [Related]
8. Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains. Saerens D; Conrath K; Govaert J; Muyldermans S J Mol Biol; 2008 Mar; 377(2):478-88. PubMed ID: 18262543 [TBL] [Abstract][Full Text] [Related]
9. A native-like artificial protein from antisense DNA. Fischer N; Riechmann L; Winter G Protein Eng Des Sel; 2004 Jan; 17(1):13-20. PubMed ID: 14985533 [TBL] [Abstract][Full Text] [Related]
10. The folding process of acylphosphatase from Escherichia coli is remarkably accelerated by the presence of a disulfide bond. Parrini C; Bemporad F; Baroncelli A; Gianni S; Travaglini-Allocatelli C; Kohn JE; Ramazzotti M; Chiti F; Taddei N J Mol Biol; 2008 Jun; 379(5):1107-18. PubMed ID: 18495159 [TBL] [Abstract][Full Text] [Related]
11. Production of functional single-chain Fv antibodies in the cytoplasm of Escherichia coli. Jurado P; Ritz D; Beckwith J; de Lorenzo V; Fernández LA J Mol Biol; 2002 Jun; 320(1):1-10. PubMed ID: 12079330 [TBL] [Abstract][Full Text] [Related]
12. Folding of an antibody variable domain in two functional conformations in vitro: calorimetric and spectroscopic study of the anti-ferritin antibody VL domain. Tsybovsky Y; Shubenok DV; Kravchuk ZI; Martsev SP Protein Eng Des Sel; 2007 Oct; 20(10):481-90. PubMed ID: 17962224 [TBL] [Abstract][Full Text] [Related]
13. High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm. Venturi M; Seifert C; Hunte C J Mol Biol; 2002 Jan; 315(1):1-8. PubMed ID: 11771962 [TBL] [Abstract][Full Text] [Related]
14. Intrabody construction and expression III: engineering hyperstable V(H) domains. Wirtz P; Steipe B Protein Sci; 1999 Nov; 8(11):2245-50. PubMed ID: 10595527 [TBL] [Abstract][Full Text] [Related]
15. Engineering the independent folding of the subtilisin BPN' prodomain: analysis of two-state folding versus protein stability. Ruvinov S; Wang L; Ruan B; Almog O; Gilliland GL; Eisenstein E; Bryan PN Biochemistry; 1997 Aug; 36(34):10414-21. PubMed ID: 9265621 [TBL] [Abstract][Full Text] [Related]
16. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer]. Wang Y; Li X; Chen W Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168 [TBL] [Abstract][Full Text] [Related]
17. Antibody scFv fragments without disulfide bonds made by molecular evolution. Proba K; Wörn A; Honegger A; Plückthun A J Mol Biol; 1998 Jan; 275(2):245-53. PubMed ID: 9466907 [TBL] [Abstract][Full Text] [Related]
18. Quenching of tryptophan fluorescence by the active-site disulfide bridge in the DsbA protein from Escherichia coli. Hennecke J; Sillen A; Huber-Wunderlich M; Engelborghs Y; Glockshuber R Biochemistry; 1997 May; 36(21):6391-400. PubMed ID: 9174355 [TBL] [Abstract][Full Text] [Related]
19. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. Knappik A; Ge L; Honegger A; Pack P; Fischer M; Wellnhofer G; Hoess A; Wölle J; Plückthun A; Virnekäs B J Mol Biol; 2000 Feb; 296(1):57-86. PubMed ID: 10656818 [TBL] [Abstract][Full Text] [Related]
20. Structural tolerance of bacterial autotransporters for folded passenger protein domains. Veiga E; de Lorenzo V; Fernández LA Mol Microbiol; 2004 May; 52(4):1069-80. PubMed ID: 15130125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]